Trinity Biotech reported $26.69M in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
Abbott USD 29.45B 152M Sep/2026
Bayer EUR 37.7B 6.54B Sep/2026
Bio-Rad Laboratories USD 803.1M 100K Sep/2026
EDAP TMS EUR 17.6M 16.6M Mar/2026
J&J USD 35.8B 1.55B Sep/2026
Mesa Laboratories USD 104.2M 104.3M Sep/2024
OraSure Technologies USD 100K 17K Dec/2025
Plus Therapeutics USD 3.79M 322K Dec/2022
Roche Holding CHF 25.22B 2.21B Jun/2026
Siemens EUR 39.41B 1.91B Sep/2026
Thermo Fisher Scientific USD 39.11B 73M Sep/2026
Tosoh JPY 92.54B 3.48B Sep/2026
Trinity Biotech USD 26.69M 10.36M Mar/2026
Veracyte USD 0 0 Mar/2025